🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

QV Bioelectronics Congrats team, QV Bioelectronics has been shortlisted for potential inclusion on our MedTech 50 ranking! Voting is now open: businesscloud.co.uk/medtech-50-vot…

Chris Bullock from QV Bioelectronics speaking about his career and lessons learned from building a #biomaterials based business

📢 Exciting news as CPI Enterprises invest in QV Bioelectronics's GRACE medical device which could increase long-term survival for people with the most common and aggressive type of #braintumours. Fantastic to see two Bruntwood SciTech customers working together🔄 🤝 alderleypark.co.uk/news/2023/6/26…

🌞 Exciting News: Welcome Michaela Baek, Our New Summer Intern at QV Bioelectronics! 🌱 Michaela, an aspiring biologist, is eager to deepen her understanding of the therapy development process, while also honing her technical skills within a medical devices company. #Welcome

Excited to be one of the presenting companies at #LSIEurope23

QV Bioelectronics and @IncubateBio announce successful outcome of strategic collaboration to accelerate new treatment option for Glioblastoma qvbio.co.uk/qv-bioelectron…

Our IDH mutant glioma heterogeneity paper with Holger Heyn is out in Cell Reports Medicine. A wonderful collective effort by Enrique Blanco Carmona, Ashwin, Inma, and @JuanCNieto1. Special thanks to Matthias and Luigi. Looking forward to expanding on this work! cell.com/cell-reports-m…

🎉Presenting in the #Oncology Therapeutic Category at Innovation Summit San Francisco 2023 is Presenting Company QV Bioelectronics (QV Bioelectronics) with CEO Christopher Bullock. 🎉 Welcome to #InnovationSF23, Chris and the QV Bioelectronics team! We are delighted to have you.

Now Presenting: Christopher Bullock of QV Bioelectronics (Cheshire, UK). They are developing the world’s first implantable electric field therapy device to treat aggressive brain cancers. Are you staying informed? bit.ly/3G0kLGa

We will be at the 28th Annual Meeting for the SNO this week at the Vancouver Convention Centre !🍁 Ryan Purdy and Tomisin Olukoga will be presenting our exciting pre-clinical work using Electric Field Therapy (EFT). 💬

@InnovateUK & UK in Texas hosted Rt Hon Michelle Donelan on her visit to Texas Medical Center to meet the latest cohort of UK-based #DigitalHealth & #Medical device startups participating in the TMC Innovation accelerator, part of Innovate UK's Global Incubator Programme. ⚕️ow.ly/5vwI50Q8EP1

Our Alderley Park campus offers state-of-the-art labs where ideas can flourish. Just look at these pics of QV Bioelectronics’s new space!😍 💡Growing their business at #AlderleyPark, QV Bio is a start-up developing surgically implantable #medical devices to treat malignant brain tumours🔬

March is Brain Tumor Awareness Month. Our startup is dedicated to innovation in this field, emphasising the critical need for community support and groundbreaking approaches. #BrainTumorAwareness

🚀 Exciting news! QV has secured £343,000 from Innovate UK to develop the world’s first fully implantable Electric Field Therapy (EFT) device for childhood brain cancers. 🎗️ This supports early-stage development & testing, advancing new options and expanding our portfolio.

QV Bioelectronics secures £343,000 from Innovate UK’s Cancer Therapeutics programme to develop a new treatment for childhood brain tumours

ricardo chavarriaga @sameermzuberi Alice Accorroni AbbVie Jean Schoenen Belgian Brain Council Madalena Plácido 🎙️ Lisa Burke 🌍 European Academy of Neurology vCreate Health 💙 After a rigorous selection process, 5 innovative start-ups are pitching their ground-breaking solutions in the brain health space! 🧠💡  🎤 QV Bioelectronics , BrainTale, CREATe Therapeutics, Paperbox and RebrAIn take the stage for this pitch competition in front of five jury members!

Excited to welcome Carl Daintree as QV's new COO! 🚀 Carl brings expertise across medtech, pharma & biotech. At 30 Technology, he led products from prototype to exit, driving clinical studies & market strategy. Thrilled to have him as we advance brain tumour treatment! 🧠

⏳ We’ve got some exciting news to share tomorrow at QV Bioelectronics. Looking forward to sharing more very soon.

🚨 Big news at QV Bioelectronics! We've been awarded £1.2M by Innovate UK as part of the Biomedical Catalyst to support preparations for a first-in-human trial of GRACE. Full Press Release: shorturl.at/kxOtX #BiomedicalCatalyst #InnovateUKFunded